Compugen Ltd (CGEN)
1.41
-0.08
(-5.37%)
USD |
NASDAQ |
Nov 15, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Compugen Revenue (TTM): 59.85M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.85M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.712M |
| September 30, 2016 | 8.972M |
| June 30, 2016 | 9.131M |
| March 31, 2016 | 8.858M |
| December 31, 2015 | 9.278M |
| September 30, 2015 | 7.517M |
| June 30, 2015 | 9.006M |
| March 31, 2015 | 10.75M |
| December 31, 2014 | 12.37M |
| September 30, 2014 | 7.59M |
| June 30, 2014 | 7.462M |
| March 31, 2014 | 5.52M |
| December 31, 2013 | 3.549M |
| September 30, 2013 | 1.908M |
| June 30, 2013 | 0.426M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
59.85M
Minimum
Sep 2024
59.85M
Maximum
Sep 2024
59.85M
Average
59.85M
Median
Sep 2024
Revenue (TTM) Benchmarks
| Pluri Inc | 0.326M |
| BioLine Rx Ltd | -- |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | 0.743M |
| BiomX Inc | -- |